KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Income from Non-Controlling Interests (2016 - 2023)

Biogen (BIIB) has 14 years of Income from Non-Controlling Interests data on record, last reported at -$200000.0 in Q3 2023.

  • For Q3 2023, Income from Non-Controlling Interests fell 200.0% year-over-year to -$200000.0; the TTM value through Mar 2024 reached $1.2 million, up 100.25%, while the annual FY2022 figure was -$85.3 million, 149.74% down from the prior year.
  • Income from Non-Controlling Interests reached -$200000.0 in Q3 2023 per BIIB's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $64.4 million in Q2 2020 and bottomed at -$388.7 million in Q4 2021.
  • Average Income from Non-Controlling Interests over 4 years is -$51.8 million, with a median of -$250000.0 recorded in 2023.
  • The widest YoY moves for Income from Non-Controlling Interests: up 99.65% in 2023, down 200.0% in 2023.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at $64.4 million in 2020, then crashed by 703.57% to -$388.7 million in 2021, then soared by 100.05% to $200000.0 in 2022, then plummeted by 200.0% to -$200000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were -$200000.0 in Q3 2023, $1.7 million in Q2 2023, and -$300000.0 in Q1 2023.